Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Asset / Drug

Digital

Drug and asset intelligence for Digital with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
5
Catalysts
0
Stage
Development stage unavailable

Sponsor company

pharma companies in neurology →

Recent signals(5)

ClinicalAugust 7, 2026

Digital Lifestyle Intervention Trial Aims to Improve Cardiovascular Health Outcomes

A multi-center randomized controlled trial is evaluating a digital lifestyle intervention's impact on cardiovascular health in Swedish primary healthcare.

ClinicalJuly 11, 2026

Digital Tomosynthesis Mammography Shows Promise in Breast Cancer Screening

A randomized phase III trial suggests that digital tomosynthesis mammography may be superior to digital mammography for breast cancer screening.

Clinical
July 10, 2026

Digital Health Intervention for Young Adult Cancer Survivors Under Study

A study is underway to evaluate a digital health intervention aimed at improving well-being in young adult cancer survivors.

ClinicalJuly 7, 2026

Digital Biomarkers for Monitoring Limb Function in Inclusion Body Myositis

A study is validating digital biomarkers for monitoring upper limb function in Inclusion Body Myositis using wearable sensors.

ClinicalJune 26, 2026

Digital Health Tools Show Promise in Accelerating Lifestyle Habit Formation for Diabetes Risk

A randomized controlled trial is assessing the effectiveness of a digital intervention in accelerating healthy habit formation in adults at risk for Type 2 Diabetes.

Upcoming milestones

No catalysts indexed for this entity yet.

Related catalysts

No catalysts indexed for this entity yet.

Indications

Breast Cancer →
Cardiovascular Disease →
Type 2 Diabetes →

Therapeutic areas

Breast Cancer →
Cardiovascular Disease →
Digital Health →
Endocrinology →
Inclusion Body Myositis →
Neurology →
Oncology →
Type 2 Diabetes →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.